316 related articles for article (PubMed ID: 27165095)
41. Evaluation of Female Fertility-AMH and Ovarian Reserve Testing.
Cedars MI
J Clin Endocrinol Metab; 2022 May; 107(6):1510-1519. PubMed ID: 35100616
[TBL] [Abstract][Full Text] [Related]
42. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
[TBL] [Abstract][Full Text] [Related]
43. Assessment of ovarian reserve in euthyroid adolescents with Hashimoto thyroiditis.
Pirgon O; Sivrice C; Demirtas H; Dundar B
Gynecol Endocrinol; 2016; 32(4):306-10. PubMed ID: 26608409
[TBL] [Abstract][Full Text] [Related]
44. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
45. Comparison of markers of ovarian reserve between patients with complete müllerian agenesis and age-matched fertile and infertile controls.
Ozekinci M; Erman Akar M; Senol Y; Ozdem S; Uzun G; Daloglu A; Ongut G
Fertil Steril; 2015 Jul; 104(1):176-9. PubMed ID: 26025811
[TBL] [Abstract][Full Text] [Related]
46. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
[TBL] [Abstract][Full Text] [Related]
47. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
48. Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-Müllerian hormone levels in normo-ovulatory women.
Lee JE; Yoon SH; Kim HO; Min EG
J Korean Med Sci; 2015 Mar; 30(3):296-300. PubMed ID: 25729253
[TBL] [Abstract][Full Text] [Related]
49. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
[TBL] [Abstract][Full Text] [Related]
50. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
[TBL] [Abstract][Full Text] [Related]
51. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
52. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
[TBL] [Abstract][Full Text] [Related]
53. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
54. Psychological stress is related to a decrease of serum anti-müllerian hormone level in infertile women.
Dong YZ; Zhou FJ; Sun YP
Reprod Biol Endocrinol; 2017 Jul; 15(1):51. PubMed ID: 28693593
[TBL] [Abstract][Full Text] [Related]
55. Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation.
Fabbri R; Macciocca M; Melotti C; Pasquinelli G; Vicenti R; Bacchi Reggiani ML; Terribile D; Venturoli S
Future Oncol; 2014 Jun; 10(8):1343-51. PubMed ID: 25052745
[TBL] [Abstract][Full Text] [Related]
56. [Anti-Müllerian hormone is a clinical useful measure of the ovarian reserve].
Hyldgaard JM; Ingerslev HJ; Tørring N; Madsen HN; Bor P
Ugeskr Laeger; 2015 Jan; 177(5):V09140477. PubMed ID: 25650516
[TBL] [Abstract][Full Text] [Related]
57. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
[TBL] [Abstract][Full Text] [Related]
58. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
[TBL] [Abstract][Full Text] [Related]
59. Association between thyroid autoimmunity and the decline of ovarian reserve in euthyroid women.
Li Z; Xu S; Luo W; Hu J; Zhang T; Jiao X; Qin Y
Reprod Biomed Online; 2022 Sep; 45(3):615-622. PubMed ID: 35732549
[TBL] [Abstract][Full Text] [Related]
60. Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.
Kallio S; Aittomäki K; Piltonen T; Veijola R; Liakka A; Vaskivuo TE; Dunkel L; Tapanainen JS
Hum Reprod; 2012 Mar; 27(3):854-60. PubMed ID: 22258659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
